DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 198 filers reported holding DEPOMED INC in Q1 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $145,000 | -14.2% | 13,500 | 0.0% | 0.02% | -16.7% |
Q1 2017 | $169,000 | -32.9% | 13,500 | -3.6% | 0.02% | -38.5% |
Q4 2016 | $252,000 | -27.8% | 14,000 | 0.0% | 0.04% | -29.1% |
Q3 2016 | $349,000 | +26.9% | 14,000 | 0.0% | 0.06% | +19.6% |
Q2 2016 | $275,000 | +41.0% | 14,000 | 0.0% | 0.05% | +35.3% |
Q1 2016 | $195,000 | -23.2% | 14,000 | 0.0% | 0.03% | -26.1% |
Q4 2015 | $254,000 | -3.8% | 14,000 | 0.0% | 0.05% | -6.1% |
Q3 2015 | $264,000 | -12.0% | 14,000 | 0.0% | 0.05% | -5.8% |
Q2 2015 | $300,000 | -36.2% | 14,000 | -33.3% | 0.05% | -36.6% |
Q1 2015 | $470,000 | +32.8% | 21,000 | -4.5% | 0.08% | +28.1% |
Q4 2014 | $354,000 | +6.0% | 22,000 | 0.0% | 0.06% | +4.9% |
Q3 2014 | $334,000 | +6.7% | 22,000 | -2.2% | 0.06% | +3.4% |
Q2 2014 | $313,000 | -4.3% | 22,500 | 0.0% | 0.06% | -10.6% |
Q1 2014 | $327,000 | +37.4% | 22,500 | 0.0% | 0.07% | +40.4% |
Q4 2013 | $238,000 | +41.7% | 22,500 | 0.0% | 0.05% | +27.0% |
Q3 2013 | $168,000 | +32.3% | 22,500 | 0.0% | 0.04% | +23.3% |
Q2 2013 | $127,000 | – | 22,500 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DELTEC ASSET MANAGEMENT LLC | 2,252,402 | $31,376,000 | 7.88% |
Healthcare Value Capital, LLC | 350,000 | $4,876,000 | 7.16% |
Senvest Management, LLC | 4,977,256 | $69,333,000 | 5.82% |
Consonance Capital Management LP | 2,756,360 | $38,396,000 | 5.81% |
Opaleye Management Inc. | 325,000 | $4,527,000 | 2.82% |
Krensavage Asset Management, LLC | 447,000 | $6,227,000 | 2.23% |
Healthcare Value Capital, LLC | 100,000 | $1,393,000 | 2.05% |
Starboard Value LP | 2,950,000 | $41,094,000 | 1.44% |
HealthInvest Partners AB | 200,000 | $2,786,000 | 1.30% |
OAK RIDGE INVESTMENTS LLC | 7,206,286 | $100,384,000 | 1.29% |